1164 19f NMR analysis of 5 fluorocytosine metabolism in cytosine deaminase transfected dunning r3327 AT 1 rat prostate cells; failure of the bystander effect

1164 19F NMR Analysis of 5 Fluorocytosine Metabolism in Cytosine Deaminase Transfected Dunning R3327 AT 1 Rat Prostate Cells; Failure of the Bystander Effect Molecular Therapy Vol 5, No 5, May 2002, P[.]

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

S378

 " ? 

1

1162 Development of HIV 162 Development of HIV 162 Development of HIV-Derived Lentiviral V -Derived Lentiviral V -Derived Lentiviral Vectors ectors

for Gene Therapy of Hepatocellular Carcinoma

Rathviro Uch, 1,4 René Gérolami, 1,3,4 Jean Hardwigsen, 3 Jorge

Cardoso, 2 Franck Dodero, 4 Sylvie Mathieu, 4 Claude Bagnis, 1

Christian Bréchot, 2 Patrice Mannoni 1

Français du sang Alpes Méditerranée, Marseille, France;

1

1163 Directed In V 163 Directed In V 163 Directed In Vivo Evolution of Retroviruses ivo Evolution of Retroviruses

Activatable by T

Activatable by Tumour-Associated Matrix umour-Associated Matrix

Metalloproteases

R Schneider, 1 Y Medvedovska, 1 B Voelker, 1 M Chadwick, 2 S.

Russel, 3 C Buchholz, 1 K Cichutek 1

##!", 

1

1164 164 19 F-NMR F-NMR Analysis of 5-Fluorocytosine Metabolism Analysis of 5-Fluorocytosine Metabolism

in Cytosine Deaminase-T

in Cytosine Deaminase-Transfected Dunning R3327 ransfected Dunning R3327 ransfected Dunning R3327 A A AT T T-1 -1 Rat Prostate Cells; Failure of the Bystander Effect

Heike Corban-Wilhelm, 1 William E Hull, 2 Juergen Debus 1

85

: 85

? &9

 5B

)*)&9

85 ?"

&9 85

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts

&9

1

1165 Hypoxia Driven Gene Therapy T 165 Hypoxia Driven Gene Therapy T 165 Hypoxia Driven Gene Therapy To T o T o Target arget

Radiation Resistant T

Radiation Resistant Tumours umours

Rachel L Cowen, 1 Naomi Chadderton, 1 Kaye J Williams, 1 Adam V.

Patterson, 2 Brian A Telfer, 1 Ian J Stratford 1

1

1166 Selective Killing of Cancer Cells through 166 Selective Killing of Cancer Cells through

T

Translational Regulation of the HTK/GCV Gene Therapy ranslational Regulation of the HTK/GCV Gene Therapy

System

Robert DeFatta, 1 Robert Chervenak, 1 Arrigo DeBenedetti 1

@B*(?+ (*<)+)  )+*  :+ **;+('  :( 

*(':)))989=

1

1167 167 167 A A A Fully Human Fully Human Fully Human Anti-Ep-CAM scFv- Anti-Ep-CAM scFv-

βββββ -Glucuronidase Fusion Protein for Extracellular Activation

of a Glucuronide Prodrug of Doxorubicin in Suicide Gene Therapy

Michelle de Graaf, 1 Dinja Oosterhoff, 1 Frank A E Kruyt, 1 Herbert

M Pinedo, 1 Hidde J Haisma, 2 Epie Boven 1

of Therapeutic Gene Modulation, University Centre of Pharmacy,

1< /b>

11 66 Selective Killing of Cancer Cells through 16 6 Selective Killing of Cancer Cells through

T

Translational Regulation... May 2002, Part of Parts

&9

1< /b>

11 65 Hypoxia Driven Gene Therapy T 1 65 Hypoxia Driven Gene Therapy T 1 65 Hypoxia Driven Gene Therapy To T... Regulation of the HTK/GCV Gene Therapy ranslational Regulation of the HTK/GCV Gene Therapy

System

Robert DeFatta, Robert Chervenak, Arrigo DeBenedetti 1< /small>